Embracing the Future: Anti-Aging Technology – The Senescence Revolution
The realm of anti-aging has been revolutionized by ground-breaking research and technology, a testament to human ingenuity and the relentless pursuit of longevity. A recent feature in the Women’s IP World Annual 2024, titled “Anti-Aging Technology – The Senescence Revolution,” penned by the innovative minds at PatWorld, casts a spotlight on the strides being made in this field.
Unveiling the Secrets of Senescence
Cellular senescence, a state where cells cease to divide yet remain metabolically active, plays a pivotal role in aging. The article delves into how understanding and manipulating this process can lead to significant anti-aging breakthroughs, promising a future where the effects of aging can be drastically mitigated.
Innovations at the Forefront
PatWorld’s experts provide an overview of the latest technologies and therapies that target cellular aging. These include genetic modifications, pharmaceutical interventions, and lifestyle changes that together form a comprehensive approach to extending the human health-span.
A Testament to Collaborative Genius
Highlighting the collaborative spirit within the scientific community, the article emphasizes the importance of shared knowledge and cross-disciplinary efforts in pushing the boundaries of what’s possible in anti-aging research.
Looking Ahead
The journey toward conquering aging is filled with challenges and opportunities. As we stand on the brink of a new era, the insights from “Anti-Aging Technology – The Senescence Revolution” not only inform but inspire continued exploration and innovation in the quest for longevity.
Chelsey Edwards – Patent Analyst at PatWorld on the Biotech team, specialising in Biotechnology, Medicine and Pharmaceuticals.
Chulin Dai – Senior Patent Analyst at PatWorld on the Chemistry team, specialising in Bio-Chemistry, Medicine and Pharmaceuticals.
Are you or your clients developing technologies in this critical area? Are you seeking support with IP Search Services or Patent Databases? If so, please click on the relevant links below.
If you enjoy our content here, you’ll love the stuff we share on LinkedIn, follow us now. However, if you’re not on LinkedIn, check out our other social media sites:
With 1 in 10 people living with Diabetes globally (537 million), and this is expected to rise to 643 million by 2030 and 783 million by 2045[i], finding new ways of preventing, diagnosing, and treating the disease is crucial. To celebrate World Diabetes Day 2023 we take a look at what innovations are being developed in the Health Technology sector relating to diabetes. To do this we initially ran a simple search on diabetes and isolated the search to the last five years publications only.
During this time, there have been almost 300k patent publications relating to Diabetes. As Figure 1 shows the patents are in a variety of classifications. However, almost a quarter of the publications relate to classification codes A61B5/145[ii] (Measuring Characteristics of Blood in Vito) and A61B5/00[iii] (Measuring for Diagnostic Purposes) and we will look at the innovators in this space and highlight a few of their patents.
Figure 1
Who are the main players in Diabetes Monitoring?
Figure 2 shows Roche, Dexcom, and Medtronic dominate, and we will showcase some of their recent patents.
Figure 2
Roche Diagnostics – Patent number US2020250939A1 MEDICAL DEVICE ALERT, OPTIMIZATION, PERSONALIZATION, AND ESCALATION
Figure 3 – Patent number US2020250939A1
This patent alerts the user via a message sent to their watch, smartphone, smart speaker, etc that their glucose levels have changed. The alerts will get progressively louder/stronger until the user acknowledges the message.
Dexcom – Patent number US2023138673A1 – RANKING FEEDBACK FOR IMPROVING DIABETES MANAGEMENT
Figure 4 Patent number US2023138673A1
This patent is a method for providing feedback based on glucose measurements. Readings are taken and analysed against historical data with alerts sent to the wearer advising if readings are higher/lower than normal at periodic times. Ways to make improvements are suggested if particular actions are taken, ie exercise activity.
Medtronic – Patent US2022143314A1 – DIABETES THERAPY BASED ON DETERMINATION OF FOOD ITEM
Figure 5 Patent number US2022143314A1
This patent by Medtronic discloses a method for adapting diabetes therapy based on what a person eats. Using a mixture of wearable devices and cameras, information is generated allowing therapy to be tailored to the individual based on their diet.
Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; {Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue}(measuring of blood pressure or blood flow A61B5/02; non-radiation detecting or locating of foreign bodies in blood A61B5/06)
Measuring for diagnostic purposes (radiation diagnosis A61B6/00; diagnosis by ultrasonic, sonic or infrasonic waves A61B8/00); Identification of persons
Are you developing new inventions around Diabetes?
At PatWorld, we understand the importance of protecting your #HealthTech inventions, and we can provide our clients with accurate, reliable, and cost-effective information and services tailored to meet individual needs.
Patent, Design, and Trademark Research Experts with a combined experience of over 100 years in Intellectual Property searching. Highly trained, dynamic in-house research teams specialising in a wide range of subject matter. All our analysts follow a training program developed by former IPO Examiners. Our teams are available to discuss any specific technical points regarding your search enquiries.
Order a Search Now